UNSPSC 51272900: Anaesthetic phenols

Anaesthetics based on benzene derivatives that include one or more hydroxyl groups attached to the ring structure.

UNSPSC 51272900 Anaesthetic phenols is a Class code that covers pharmaceutical products state and local governments procure to support public health, emergency response, and community health initiatives. Recent solicitations show state and local agencies buying naloxone (opioid-reversal medication), generic multi-source pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing vehicles. The mix of issuing bodies reflects both individual county health departments and multi-state cooperative purchasing alliances. Seminole County, Florida, for example, recently sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB (IFB60459723LAS), with quarterly deliveries supporting community health initiatives. Vendors bidding on pharmaceutical procurements at this tier must typically meet federal compliance requirements—including cGMP and Drug Supply Chain Security Act (DSCSA) certification—along with standard state and local contractor obligations such as E-Verify authorization, workers' compensation, and commercial general liability insurance.

Geographic activity spans multiple states, with recent opportunities concentrated in Florida, Texas, and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 (S1070000015802) for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, distributing contracts across participating state and local government facilities in Minnesota and Oregon through three authorized wholesalers. Texas Health and Human Services Commission released an RFI in April 2026 (HHS0017013) to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities, signaling state-level interest in alternative pharmaceutical distribution models. The Seminole County IFB closed July 26, 2023, with a two-year initial term and one-year renewal option. Cooperative purchasing vehicles like MMCAP dominate the larger-dollar opportunities in this category, typically using weighted evaluation criteria (price competitiveness at 75 percent in the MMCAP case) and requiring vendors to maintain relationships with established drug wholesalers and comply with administrative fee structures.